Interestingly, in a breast cancer model, BafA1 treatment reduces the growth in cells expressing membrane-tethered, constitutively active NOTCH1 forms, while sparing cells expressing cytoplasmic forms [107]. The gene discussed is NOTCH1; the disease is breast cancer.